Bone Resorption by Osteoclasts
Steven L. Teitelbaum · Science · 2000
Osteoporosis, a disease endemic in Western society, typically reflects an imbalance in skeletal turnover so that bone resorption exceeds bone formation. Bone resorption is the unique function of the osteoclast, and anti-osteoporosis therapy to date has targeted this cell. The osteoclast is a specialized macrophage polykaryon whose differentiation is principally regulated by macrophage colony-stimulating factor, RANK ligand, and osteoprotegerin. Reflecting integrin-mediated signals, the osteoclast develops a specialized cytoskeleton that permits it to establish an isolated microenvironment between itself and bone, wherein matrix degradation occurs by a process involving proton transport. Osteopetrotic mutants have provided a wealth of information about the genes that regulate the differentiation of osteoclasts and their capacity to resorb bone.
Cited by 3,957 works. doi:10.1126/science.289.5484.1504
Authors
References
- Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
- OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
- The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene
- TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
- c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling
- Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
- Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.
- Requirement for NF-κB in osteoclast and B-cell development